ScienceDaily·4 min read·hard
A hidden weakness in deadly cancers could lead to powerful new treatments
✦AI Summary
UCLA researchers have identified that certain aggressive cancers lacking the RB gene are highly dependent on the E2F3 protein for survival. Blocking this protein could offer a new therapeutic strategy for treating difficult-to-cure tumors in the lung, prostate, and ovary.
Researchers at UCLA have identified a hidden weakness in some of the most aggressive and difficult-to-treat cancers, raising hopes for a new way to attack tumors that have resisted treatment for decades.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in